Journal of Cardiothoracic and Vascular Anesthesia
Volume 22, Issue 4 , Pages 548-553 , August 2008

Cardioprotective Effects of Nicorandil in Patients Undergoing On-Pump Coronary Artery Bypass Surgery

References 

  1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–1136
  2. Ishihara M, Sato H, Tateishi H, et al. Implications of prodromal angina pectoris in anterior wall acute myocardial infarction: Acute angiographic findings and long-term prognosis. J Am Coll Cardiol. 1997;30:970–975
  3. Wu Z, Iivainen T, Pehkonen E, et al. Ischemic preconditioning suppressed ventricular tachyarrhythmias after myocardial revascularization. Circulation. 2002;106:3091–3096
  4. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium cannels prevents myocardial preconditioning in dogs. Circ Res. 1992;70:223–233
  5. Grover GJ, Sleph PG, Dzwonczyk S. Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1 receptors. Circulation. 1992;86:1310–1316
  6. Auchampach JA, Grover GJ, Gross GJ. Blockade of ischaemic preconditioning in dogs by the novel ATP-dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res. 1992;26:1054–1062
  7. Gross GJ, Peart JN. KATP channels and myocardial preconditioning: An update. Am J Physol Heart Circ Physiol. 2003;285:921–930
  8. Sato T, Sasaki N, O'ourke B, et al. Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels. J Am Coll Cardiol. 2000;35:514–518
  9. IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: The Impact Of Nicorandil in Angina (IONA) randomized trial. Lancet. 2002;359:1269–1275
  10. Patel DJ, Purcell HJ, Fox KM. Cardioprotection by opening of the KATP channel in unstable angina. Eur Heart J. 1999;20:51–57
  11. Kawamura T, Kadosaki M, Nara N, et al. Nicorandil attenuates NF-κB activation, adhesion molecule expression, and cytokine production in patients with coronary artery bypass surgery. Shock. 2005;24:103–108
  12. Ito I, Hayashi Y, Kawai Y, et al. Prophylactic effect of intravenous nicorandil on perioperative myocardial damage in patients undergoing off-pump coronary artery bypass surgery. J Cardiovasc Pharmacol. 2004;44:501–506
  13. Hayashi Y, Sawa Y, Ohtake S, et al. Controlled nicorandil administration for myocardial protection during coronary artery bypass grafting under cardiopulmonary bypass. J Cardiovasc Pharmacol. 2001;38:21–28
  14. Kaneko T, Saito Y, Hikawa Y, et al. Dose-dependent prophylactic effect of nicorandil, an ATP-sensitive potassium channel opener, on intraoperative myocardial ischaemia in patients undergoing major abdominal surgery. Br J Anaesth. 2001;86:332–337
  15. Chinnan NK, Puri GD, Thingnam SKS. Myocardial protection by nicorandil during open-heart surgery under cardioprotective bypass. Eur J Anesth. 2007;24:26–32
  16. Kersten JR, Schmeling TJ, Pagel PS, et al. Isoflurane mimics ischemic preconditioning via activation of KATP channels: Reduction of myocardial infarct size in rabbit. Anesthesiology. 1997;87:361–370
  17. Kehl F, Pagel PS, Krolikowski JG, et al. Isoflurane does not produce a second window of preconditioning against myocardial infarction in vivo. Anesth Analg. 2002;95:1162–1168
  18. Bolli R, Bhatti ZA, Tang X-L, et al. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res. 1997;81:1094–1107
  19. Banerjee S, Tang X-L, Qiu Y, et al. Nitroglycerin induces late preconditioning against myocardial stunning via a PKC-dependent pathway. Am J Physiol. 1999;277:2488–2494
  20. Kashimoto S, Makoto S, Ishiguro T, et al. Nicorandil decreases cardiac events during and after noncardiac surgery. J Clin Anesth. 2007;19:44–48
  21. Agbo-Godeau S, Joly P, Lauret P, et al. Association of major aphthous ulcers and nicorandil. Lancet. 1998;352:1598–1599
  22. Watson A, Al Ozairi O, Fraser A, et al. Nicorandil-associated anal ulceration. Lancet. 2002;360:546–547
  23. Healy CM, Smyth Y, Flint SR. Persistent nicorandil-induced oral ulceration. Heart. 2004;90:e38
  24. Hackel DB, Reimer KA, Ideker RE. Comparison of enzymatic and anatomic estimates of infarct size in man. Circulation. 1984;70:824–835
  25. Katus AH, Remppis A, Neumann FJ, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 1991;83:902–912
  26. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined-A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959–969
  27. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury (Is MB creatine kinase the choice for the 1990s?). Circulation. 1993;88:750–763
  28. Chan MY, Pronovost PJ. Clinical utility of biomarkers in myocardial injury. Curr Opin Anaesthesiol. 2004;17:49–55
  29. Ohtani T, Ueda Y, Shimizu M, et al. Association between cardiac troponin T elevation and angioscopic morphology of culprit lesion in patients with non-ST-segment elevation acute coronary syndrome. Am Heart J. 2005;150:227–233
  30. Wu Z, Pehkonen E, Laurikka J, et al. Protective effect of unstable angina in coronary artery bypass surgery. Scand Cardiovasc J. 2000;34:486–492
  31. Benoit M, Paris M, Silleran J, et al. Cardiac troponin I: Its contribution to the diagnosis of perioperative myocardial infarction and various complications of cardiac surgery. Crit Care Med. 2001;29:1880–1886
  32. Januzzi JL, Lewandrowski K, MacGillivray TE, et al. A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. J Am Coll Cardiol. 2002;39:1518–1523

PII: S1053-0770(08)00046-3

doi: 10.1053/j.jvca.2008.02.011

Journal of Cardiothoracic and Vascular Anesthesia
Volume 22, Issue 4 , Pages 548-553 , August 2008